How To Find The Right Xarelto Lawsuit For Your Specific Product Service .

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical organizations, including the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to accomplish so could be grounds for compensation. Our lawyers are operating challenging to get these hurt by the drug the compensation they're entitled to. Although bleeding is a common complication connected with anticoagulants, it has been alleged that Xarelto is a lot more unsafe than traditional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, in the event of an emergency, patients may possibly be at threat for irreversible bleeding problems, like life-threatening internal and gastrointestinal hemorrhaging. Should you or even a loved one particular suffered a significant bleeding occasion soon after taking Xarelto, you may have legal recourse. For much more details, contact us right now to possess your case reviewed, free of charge. Compensation Possibilities xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in situations of death, funeral expenses. In addition, they're searching for punitive damages, that are normally awarded to punish the defendant and deter other companies from acting similarly. Why Are Lawsuits Becoming Filed? Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug. In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging: The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors. The makers of the drug continue to market Xarelto as a safe anticoagulant option. Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication. Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event. Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting. visit here this page for more details on the alleged health risks of Xarelto. Multidistrict Litigation Trial Dates Set The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.